Status:

COMPLETED

BIBR 277 Capsules in Hypertensive Patients With Nephropathy

Lead Sponsor:

Boehringer Ingelheim

Conditions:

Hypertension

Eligibility:

All Genders

20+ years

Phase:

PHASE2

Brief Summary

The antihypertensive effect, safety and usefulness of treatment with BIBR 277 capsules were evaluated in hypertensive patients with nephropathy

Eligibility Criteria

Inclusion

  • Condition: Either of the following criteria is satisfied in laboratory tests:
  • Presence of a renal parenchymal disorder such as chronic glomerulonephritis is confirmed (serum creatinine \< 3.0 mg/dL)
  • Presence of a renal function disorder (serum creatinine ≥ 1.5 mg/dL to \< 3.0 mg/dL)
  • Age: ≥ 20 years
  • Sex: Either male or female
  • Patient status: Either outpatients or inpatients. However, the patient status should remain unchanged throughout the study period
  • Blood pressure (BP):
  • \[Outpatients\] The last 2 measurements of sitting BP out of at least 3 taken during the observation period (2 - 4 weeks) should be stable and a mean of the two measurements should be ≥160 mmHg for systolic BP (SBP) and ≥95 mmHg for diastolic BP (DBP)
  • \[Inpatients\] The last 2 measurements of supine BP taken during the observation period (1 week) should be stable and a mean of the 2 measurements should be ≥ 150 mmHg for SBP and ≥ 90 mmHg for DBP

Exclusion

  • Renovascular hypertension
  • Undergoing haemodialysis
  • Severe hypertension (Diastolic BP ≥ 120 mmHg)
  • Severe heart failure, angina pectoris, or history of myocardial infarction
  • Atrioventricular conduction disturbance (degree II to III), atrial fibrillation, or serious arrhythmia
  • Symptoms of cerebrovascular disorder
  • Serious hepatic dysfunction
  • Uncontrolled diabetes
  • Peptic ulcer
  • History of hypersensitivity to drugs
  • Hyperkalaemia
  • Undergoing treatment with a digitalis preparation
  • Pregnant, breast feeding, possibly pregnant or planning to become pregnant during this study
  • Otherwise judged ineligible by the investigator

Key Trial Info

Start Date :

August 1 1998

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

23 Patients enrolled

Trial Details

Trial ID

NCT02187484

Start Date

August 1 1998

Last Update

July 11 2014

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.